ADIPOQ and polycystic ovary syndrome: This consistency across studies underscores the role of ADIPOQ genetic variation in PCOS, although its effects may differ depending on whether the focus is on disease susceptibility or metabolic sub-phenotypes (e.g., obese vs. non-obese PCOS patients).